Self-immolative nanocapsules precisely regulate depressive neuronal microenvironment for synergistic antidepression therapy

BACKGROUND: Pharmacotherapy constitutes the first-line treatment for depression. However, its clinical use is hindered by several limitations, such as time lag, side effects, and narrow therapeutic windows. Nanotechnology can be employed to shorten the onset time by ensuring permeation across the bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ziyao, Chen, Bei, Xiang, Shijun, Hu, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433581/
https://www.ncbi.nlm.nih.gov/pubmed/37592281
http://dx.doi.org/10.1186/s12951-023-02008-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433581/
https://www.ncbi.nlm.nih.gov/pubmed/37592281
http://dx.doi.org/10.1186/s12951-023-02008-9

Ejemplares similares